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Abstract Gray-scale intravascular ultrasound
(IVUS) is the modality that has been established as
the golden standard for in vivo imaging of the vessel
wall of the coronary arteries. The use of IVUS in
clinical practice is an important diagnostic tool used
for quantitative assessment of coronary artery dis-
ease. This has made IVUS the de-facto invasive
imaging method to evaluate new interventional
therapies such as new stent designs and for athero-
sclerosis progression-regression studies. However,
the gray-scale representation of the coronary vessel
wall and plaque morphology in combination with the
limited resolution of the current IVUS catheters
makes it difﬁcult, if not impossible, to identify
qualitatively (e.g. visually) the plaque morphology
similar as that of histopathology, the golden standard
to characterize and quantify coronary plaque tissue
components. Meanwhile, this limitation has been
partially overcome by new innovative IVUS-based
post-processing methods such as: virtual histology
IVUS (VH-IVUS, Volcano Therapeutics, Rancho
Cordova, CA, USA), iMAP-IVUS (Bostoc Scientiﬁc,
Santa Clara, CA, USA), Integrated Backscatter IVUS
(IB-IVUS) and Automated Differential Echogenicity
(ADE).
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Introduction
Atherogenesis is the leading cause of cardiovascular
mortality and morbidity in the developed world. The
imaging of coronary atherosclerosis and more in
particular the high risk atheromatous plaque has
made an explosive progress the last decade with the
advent of innovative techniques that focus on the
high-resolution visualization of the coronary vascular
wall. Gray-scale intravascular ultrasound (IVUS) is
the modality that has been established as the golden
standard for in vivo imaging of the vessel wall of the
coronary arteries [1, 2]. The use of IVUS is an
important diagnostic tool used for quantitative
assessment of coronary artery disease. This has made
IVUS the de-facto invasive imaging method of choice
to evaluate new interventional therapies such as new
stent designs [3–5] and for atherosclerosis progres-
sion-regression studies [6–14]. However, the gray-
scale representation of the coronary vessel wall and
plaque morphology in combination with the limited
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difﬁcult, if not impossible, to identify qualitatively
(e.g. visually) the plaque morphology similar as that
of histopathology, the golden standard to characterize
and quantify coronary plaque tissue components.
Meanwhile, this limitation has been partially over-
come by new innovative IVUS-based post-processing
methods such as: virtual histology IVUS [15, 16]
(VH-IVUS, Volcano Therapeutics, Rancho Cordova,
CA, USA), iMAP-IVUS [17] (Bostoc Scientiﬁc,
Santa Clara, CA, USA), Integrated Backscatter IVUS
[18] (IB-IVUS) and Automated Differential Echog-
enicity [19] (ADE).
Intravascular ultrasound (IVUS) principles
The size of current IVUS catheters are ranging from
2.6 to 3.5 French (0.87–1.17 mm) and are inserted
into the coronary arteries through 6-French guiding
catheters. The principle of IVUS imaging is based on
the oscillatory movement (expansion and contraction)
of a piezoelectric transducer (crystal) in order to
produce sound waves when electrically excited.
There are two major different transducer designs
[2]: (1) the mechanical single element rotating device
and (2) the electronic phased array. The mechanical
rotating element device uses a single piezoelectric
transducer that rotates with 1,800 rotations per
minute, while the electronic phased array device uses
multiple stationary placed piezoelectric transducers
which are sequentially activated. The generated
sound waves by the transducers propagates through
the different tissues and is reﬂected according to the
acoustic properties of the tissue it travels through
[20].
Gray-scale IVUS based atheromatous plaque clas-
siﬁcation is limited due to its low spatial resolution
and for the usual IVUS transducers (20 and 40 MHz)
for which the axial resolution is 200 lm and the
lateral 200–250 lm. Based on their visual appeare-
ance, not necessarily histological composition, ath-
eromas have been classiﬁed in four categories by
gray-scale IVUS: (1) soft plaque (lesion echogenicity
less than the surrounding adventitia), (2) ﬁbrous
plaque (intermediate echogenicity between soft
(echolucent) atheromas and highly echogenic calci-
ﬁed plaques), (3) calciﬁed plaque (echogenicity
higher than the adventitia with acoustic shadowing),
and (4) mixed plaques (no single acoustical subtype
represents[80% of the plaques) [2].
IVUS based imaging modalities for
tissue characterization
To overcome the limitations of qualitative visual
interpretation of the IVUS images and to describe the
coronary plaque morphology, several post-processing
methods for computer-assisted quantiﬁcation have
been developed during the recent years. There are
two basic different approaches: (1) Signal-based
analysis (the so called raw radiofrequency analysis
or RF-analysis) and (2) Image-based analysis. The
different methods will be described below:
Tissue characterization using virtual histology
IVUS (VH-IVUS)
The ﬁrst commercial available RF-signal based tissue
composition analysis tool was the so-called virtual
histology (VH-IVUS, Volcano Therapeutics) soft-
ware. It uses in-depth analysis of the backscattered
RF-signal in order to provide a more detailed
description of the atheromatous plaque composition
and is performed with either a 20 MHz, 2.9F phased-
array transducer catheter (Eagle Eye
TM Gold, Vol-
cano Therapeutics) or 45 MHz 3.2F rotational cath-
eter (Revolution
, Volcano Therapeutics) that
acquires IVUS data electrocardiogram gated [21].
The main principle of this technique is that it uses not
only the envelope amplitude of the reﬂected RF-
signals (as gray-scale IVUS does), but uses also the
underlying frequency content to analyze the tissue
components present in coronary plaques. This com-
bined information is processed using autoregressive
models and thereafter in a classiﬁcation tree that
determines four basic plaque tissue components [15]:
(1) Fibrous tissue (dark green), (2) Fibrofatty tissue
(light green), (3) Necrotic core (red) and (4) dense
calcium (white). The current software version
assumes the presence of a media layer, which is
artiﬁcially added, positioned just at the inside of the
outer vessel contour. This technique has been com-
pared in several studies against histology in humas
and other species, see Table 1 for further details.
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123Tissue characterization using i-MAP-IVUS
Recently, another RF-based processing method has
become commercially available for coronary plaque
tissue characterization which is called iMAP-IVUS
(Boston Scientiﬁc) [17]. In principle this software is
comparable, from methodological point of view, in
brief IVUS-RF parameters are processed using auto-
regressive models and matched to a database of
known RF-signal proﬁles containing the characteris-
tics of four tissue types. The colour-coded images
contain the different colors overlaying the gray-scale
IVUS images. However, there are differences, to start
with the applied colour scheme: (1) Fibrous tissue
(light green), (2) Lipid tissue (yellow), (3) Necrotic
core (pink) and (4) Calcium (blue) [17]. Furthermore,
the applied IVUS catheter is a 40 MHz rotating single
element catheter. Ex vivo validation demonstrated
accuracies at the highest level of conﬁdence as: 97%,
98%, 95%, and 98% for necrotic, lipidic, ﬁbrotic and
calciﬁed regions respectively (Table 2)[ 17].
Tissue characterization by integrated backscatter
IVUS analysis (IB-IVUS)
IB-IVUS analysis is an alternative approach, as
compared to the 2 previous ones, using the RF-signals
of the IVUS catheters to characterize coronary plaque
tissue components. IB-IVUS analyses the RF-signals
generated by the 40 MHz mechanically rotating IVUS
catheters by applying a fast Fourier transformation of
the frequency components ofthe backscatteredsignals
calculating the intensity of the signal measured in
decibels (dB). Different tissue components reﬂect the
RF-signals at different power levels, which, according
tothedevelopers,couldbeusedtodifferentiatevarious
tissue components. Analogue to the other methods it
also applies a colourcoded overlay ontothe gray-scale
IVUS images. It comprises the following different
tissue components: (1) Calciﬁcation, (2) Fibrous
tissue, and (3) Lipidic [18, 22, 23].
Tissue characterization using, automated
differential echogenicity (ADE)
Automated differential echogenicity is a post-pro-
cessing imaging analysis method that uses IVUS
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123images to characterize atheromatous coronary plaque
components [19]. At variance with the previous
described RF-signal analysis methods, it makes use
of the differences in gray-value intensities within
the gray-scale IVUS images which are caused by the
different acoustic properties (e.g. echogenicity) of the
different tissue components. It is known that adven-
titia tissue contains mostly ﬁbrotic tissue compo-
nents. Using the relative gray-value of the adventitia
layer surrounding the external elastic membrane
(EEM), which within quantitative IVUS analysis is
detected and deﬁned as the outer vessel wall, tissue
components can be differentiated as hypo- (lower
gray-values than the adventitia) or hyperechogenic
(higher gray-values than the adventitia). Bright
structures (very high gray-levels) combined with
acoustic shadowing can be identiﬁed as calcium. The
method classiﬁes structures within these acoustic
shadowed areas as unknown as the ultrasound signal
is mostly completely reﬂected by thick layers of
calcium and is not able to penetrate it (Figs. 1 and 2).
The method has not been developed, such as the other
methods, to generate colour-coded IVUS images that
try to mimic as close as possible images as generated
by histopathology, but to quantify differences over
time to evaluate possible changes of the plaque
components induced by new therapeutic treatments.
It is of outmost importance, in order to better deﬁne
the images, to follow a certain algorithm that
includes: (1) accurate plaque identiﬁcation (e.g.
quantitative IVUS), (2) tunica adventitia deﬁnition
and grey-level intensity determination (3) normal
distribution of the gray-level intensity histogram of
the adventitia tissue (image quality control), (4)
acoustic shadowing and calciﬁcation identiﬁcation
[19]. The advantages of this method are that it can be
performed retrospectively on already acquired IVUS
data and it is independent of the applied IVUS
systems and/or catheters. However, it is recom-
mended to apply within a longitudinal study the
same console type and catheter during baseline and
follow-up examinations not only within this method
but also with respect to the other methods.
Discussion
As above described, IVUS has become over the past
20 years an important clinical intracoronary imaging
tool. It not only facilitates clinical practice but it is
also a reference method of which its quantitative
parameters are often used as endpoints in ﬁrst-in-man
studies and larger clinical trials. However, the limited
resolution, as compared to histology, and gray-scale
(256 shades of gray are used when the image is
optimal) representation, for which we humans have
only limited capabilities with our eyes to make a
distinction between them (on average we can only
discriminate 8–12 different gray-levels) combined
with the large amount of images acquired during a
pullback examination (in an IVUS study of 4 cm
there are 2,400 individual cross-sections acquired),
requires another representation of the information we
are looking for. Of course quantiﬁcation is mandatory
for research purposes and thus automated or semi-
automated computer-assisted methods are necessary.
In addition, humans can interpret colour-information
much better than gray-scale information alone and
Table 2 Similarities and differences of IVUS and IVUS-based imaging modalities
Gray-scale IVUS VH i-MAP Integrated
backscatter
Echogenicity
Type of device Mecanical and
electrical
Mechanical and
electrical
Mechanical Mechanical As IVUS
Transducer frequency 20–40 MHz 20–45 MHz 40 MHz 40 MHz As IVUS
Colour code Gray-scale Fibrous: green Fibrous: light green Fibrous: green Gray-scale
Necrotic core: red Necrotic core: pink Necrotic core: blue
Callcium: white Calcium: blue Calcium: red
Fibrofatty: light
green
Fibrofatty: yellow Fibrofatty: yellow
Backscatter radiofrequency
signal analysis
Amplitude (dB) Autoregressive
model
Fast Fourier
trannformation
Fast Fourier
transformation
Computer
analysis
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123therefore the plaque compositional tools as described
in this overview are valuable additions to the use of
standard IVUS gray-scale imaging alone. Until
recently, there was only one tool (e.g. VH IVUS)
commercially and thus widespreadly available. This
has changed, now more methods are available which
could potentially lead to different outcomes as they
are using different mathematical methods and soft-
ware algorithms. Certainly, in the near future the
different methods will possibly be applied side-by-
side in multi-center studies and it is yet unknown if
this could result in possible different study outcomes,
this needs to be explored in future research.
The name giving of virtual histology IVUS (VH-
IVUS) could possibly lead to expectations that the
results derived by this method are one-to-one com-
parable to histology, which is unfortunately not the
case. The development of the RF-signal based
methods have been performed empirically, in brief:
explanted vessels are imaged by IVUS, the pathol-
ogist performs histology and the histology results are
cross-correlated to the IVUS images. The derived and
correlated RF-signal patterns have been used to build
the signal pattern databases which are later used to
identify the plaque tissue components in vivo. The
crux in this development process is the cross-
correlation between histology and IVUS, which due
to the large differences in image resolution is difﬁcult
(by example the lateral resolution of IVUS is
200–250 lm while that for histology is 5 lm).
Although histology is considered the golden standard
it is also not free from possible artifacts, by example
during the ﬁxation and staining process. Interpreta-
tion of the images by different pathologists could also
result in interobserver related-biases. It is therefore
not realistic to expect similar results from the IVUS
derived tissue compositional tools as from quantita-
tive histology. However, if appropriately used, and
with justiﬁed expectations, these quantitative plaque
tissue compositional tools, with all of their limita-
tions, can be of great additional value to investigate
plaque compositional changes which cannot be
performed with any other imaging method. Great
care must thus be taken when trying to prove a
hypothesis using these methods which could be out of
range of the capabilities of the methods and the basic
method, e.g. IVUS itself. An example of expectations
which could lead to disappointing results when the
RF-based methods are applied is within metallic
stented segments. The RF-based methods do not have
the signal proﬁle of metallic stent struts in their tissue
signal proﬁle databases and this will thus result in an
Quantitative 
Signal 
processing
Quantitative 
Image 
processing
RF-Data
Image data
*
C
A      B     
Fibrotic
Lipidic
Necrotic
Calcified
-
Fibrous
Fibro fatty
Necrotic core
Dense calcium
Fibrosis
Dense fib.
Lipid
Calcified
Hyper
Hypo
Calcified
Unknown
DE FG
Fig. 1 A shows how an intravascular ultrasound signal is
obtained from the vessel wall within an histology image. The
greyscale IVUS image, as can be appreciated in C, is formed
by the envelope (amplitude) (B0) of the radiofrequency signal,
which is illustrated in B.B ygreyscale atherosclerotic plaque
can be classiﬁed into 3 categories: hypoechogenic, hyperecho-
genic and calciﬁed. A 4th category is deﬁned as unknown,
which is tissue that is acoustically showed (G). C shows a
cross-sectional view of a grayscale image. The blue lines limit
the actual atheroma. The frequency and power of the signal
commonly differ between tissues, regardless of similarities in
the amplitude. From the backscatter radiofrequency data
(identiﬁed by B00 in B) different types of tissue information
can be retrieved: virtual histology (D), integrated backscattered
(IB) IVUS (E) and iMAP (F). Virtual histology is able to detect
four tissue types: necrotic core, ﬁbrous, ﬁbro-fatty and dense
calcium. The tissues characterized by integrated backscattered
(IB) IVUS are lipidic, ﬁbrous and calciﬁed; and iMAP detects
ﬁbrotic, lipidic, necrotic and calciﬁed
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123artiﬁcial identiﬁcation (in some research papers this
is identiﬁed as misuse). This could later lead to
unpredictable results and thus care must be taken
applying these methods for research for which they
are not designed.
However, encouraging results have been achieved
applying the tissue composition methods to detect
and to quantify as a surrogate the absorption of the
recently introduced bioabsorbable BVS stent (BVS,
Abbott Vascular, Santa Clara,CA, USA). This infor-
mation could help to explore into more detail the
overall performance of this new stent platform.
A major limitation of the RF-based methods, as
compared to the image-based echogenicity method, is
that they do not take into account acoustic shadowed
areas. They divide every individual RF-beam into
CA
AS
CA
A
C B
Fig. 2 One of the main limitations of processing the RAW
radiofrequency data only, not taking into account other
information available, such as visible acoustic shadowing, is
that these signal processing methods identify tissue compo-
nents in these acoustic shadowed regions while IVUS does not
return any information about it. The ultrasound waves are
reﬂected at the calcium interface as can be appreciated in this
ﬁgure. A presents a histology sample of an explanted human
coronary artery of which in B the OCT image is presented and
in C the IVUS equivalent. It can be appreciated that OCT
presents the calcium very well between 6 and almost 12
o’clock. Also within the IVUS image it can be appreciated that
between 6 and 12 o’clock there is a calcium layer present due
to the white and bright interface but everything behind it is
shadowed and thus IVUS does not contain any information
deeper than this interface. When using IVUS as the only source
to estimate the plaque composition tissue within these
shadowed areas should therefore be classiﬁed as unknown
tissue
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123small regions of interest and compare the found
signal proﬁles to their databases of known tissue
proﬁles without taking into account what signal is
found in front or behind that window (e.g. the larger
picture is missing). This results in detection of tissue
behind calciﬁed areas, even if on the gray-scale IVUS
image there is only shadow visible, thus the RF-
signal will most likely contain noise (thick layers of
calcium will reﬂect all acoustic energy back to the
transducer causing the typical bright white appear-
ance on gray-scale IVUS images) (Fig. 2). This could
lead to two potential biases: (1) an observer related
bias as the outer vessel boundaries are shadowed and
thus the outer vessel contour must be interpolated by
the observer and (2) a software related bias as the
signal processing tools are not taking into account
these shadowed areas and will assign the pixels in
these regions to any of the tissue components within
their database based on the ‘‘noise’’ of the ultrasound
waves related to that area. In contrast, the image-
based method of echogenicity at ﬁrst examines every
cross-sectional IVUS image if it contains acoustic
shadowed areas and classiﬁes tissue within these
areas as unknown preventing possible software
related deviations.
Although IVUS is proven to be safe and is a well-
established method widely available, there are other
promising imaging methods, such as optical coher-
ence tomography, but for the time being they are not
capable identifying quantitatively tissue components
comparable to the described methods in this paper.
In-depth post-hoc analysis of IVUS data can be
applied to quantify coronary plaque composition and
possible changes of this composition over time which
can be aplied to evaluate new therapeutic treatment
methods. However, there is still a large scientiﬁc
debate how these different analysis methods exactly
relate to each other and to that of the golden standard
of histopathology. If these methods are also capable
of identifying possible vulnerable segments is still
under investigation.
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